Actxa’s BGEM®: A Non-Invasive Approach to Glucose Awareness Powered by AI
Updated: 4 days ago
Singapore, 17 October 2024 —Actxa Pte Ltd, a Singapore-based deep tech company, introduces its BGEM technology. Powered by a cloud-based AI-driven algorithm, BGEM offers a non-invasive solution to glucose awareness, helping individuals better understand glucose-related patterns as part of their everyday health and lifestyle.
Diabetes: A Growing Concern
In Singapore, it is projected that by 2050, at least 1 million people will be living with diabetes, with 1 out of 4 remaining undiagnosed¹. Globally, the number of diabetic individuals is expected to reach about 643 million by 2030, with 1 in 2 adults undiagnosed². As glucose plays an important role in overall metabolic health, building greater awareness of glucose patterns can help individuals better understand how everyday factors such as meals, physical activity, sleep and other lifestyle habits may affect their bodies.
A Non-Invasive Approach to Glucose Awareness
BGEM leverages advanced photoplethysmography (PPG) sensors to offer a non-invasive solution. By integrating this technology into wearables, BGEM allows users to assess their diabetic risk regularly. This could support and promote early intervention, leading to better health outcomes while reducing long-term pain and cost for individuals.
A joint study by Actxa and KK Women’s and Children’s Hospital (“KKH”), titled “Utility of photoplethysmography in detecting elevated blood glucose among non-diabetics” and published in the Singapore Medical Journal, explored the use of PPG signals for non-invasive blood glucose detection.
The study supports ongoing research into how PPG-enabled wearable technologies and digital biomarkers may contribute to greater glucose awareness. The full study can be accessed here.
Clinical Validation and Global Partnerships
BGEM underwent its first clinical trials in 2022, with its first scientific paper published in 2023. The technology has continued to gain attention for its potential to make glucose-related insights more accessible through non-invasive technology.
Actxa continues to collaborate with research institutions and international partners to explore the broader potential of BGEM®, while advancing the development of locally created health technologies in Singapore.
Alleviating Financial Strain Through Diabetes Prevention
With metabolic health becoming an increasingly important part of overall wellbeing, there is growing interest in helping individuals better understand how their daily habits affect their bodies.
By providing greater awareness of glucose-related patterns, BGEM® can support individuals in reflecting on everyday factors such as food choices, physical activity, sleep and recovery.
These insights can help encourage more informed lifestyle choices and make glucose awareness a more practical part of everyday health management.
In Singapore, the healthcare system faces significant strain due to the rising number of diabetes cases, with around $940 million spent on diabetes-related care in 2017³. Technologies that encourage greater health awareness and healthier everyday behaviours can play a role in supporting broader preventive health efforts over time.
Innovating for a Healthier Future
Marcus Soo, Chief Executive Officer of Actxa, said, “As a company with a vision to help people live healthier and longer lives through technology, we are dedicated to translating technological innovations into evident solutions that enhance lives. BGEM simplifies the monitoring process, allowing users to gain insights into their health regularly and non-invasively.
By continuing to collaborate with partners and refine our technology, we hope to empower more individuals to manage their health proactively. We believe this can lead to better outcomes and support the sustainability of healthcare systems.”
Actxa is committed to improving the lives of those affected by diabetes through cutting-edge technology and meaningful collaborations.
References:
For further information, please contact:
About Actxa
Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions.
We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring.
To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.
Learn more about Actxa at www.actxa.com.
